Per Methi

Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA.

McNeil Consumer Healthcare manufactures medicals products. It offers headache and muscle pain, arthritis pain, sinus, cold, flu, sleep and pain products as well as products for children and infants. The company is headquartered in Guelph, Canada.

Trireme Medical LLC develops and manufactures novel stent technology for the treatment of atherosclerotic disease. It offers coronary stent systems, balloon catheters, and percutaneous transluminal coronary angioplasty balloon catheters for the treatment of coronary and peripheral arterial disease. The company is focused on the United States and the emerging Asian markets. The company was founded by Eitan Konstantino and Feld Tanhum in 2005 and is headquartered in Pleasanton, CA,

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

Amoun Pharmaceutical Co. SAE manufactures and distributes human and veterinary pharmaceutical products and food supplements. The firm’s products include analgesics, anti-infectives, cardiovascular and gastrointestinal drugs and drugs for anesthesia, genito-urinary disorders, and respiratory systems. The company was founded by Sarwat Bassily in 1976 and is headquartered in Cairo, Egypt.

PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas.

Johnson & Johnson Pvt. Ltd. manufactures healthcare products. The firm operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The company was incorporated on September 05, 1957 and is headquartered in Mumbai, India.

Leader Dogs for the Blind engages in the provision of guide dog training services. It also offers orientation and mobility training, and summer experience camp program. The company was founded by Charles A. Nutting, Donald P. Schuur and S.A. Dodge in 1939 and is headquartered in Rochester, MI.

Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.

Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.

Innoblative Designs, Inc. develops energy medical devices. Its device Sira, is a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. The company was founded by Tyler Wanke and is headquartered in Chicago, IL.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

Intrinsic Capital Partners is a private equity/venture capital firm founded by Gerald Stahlecker, Cornelius Merlini, and Howard Goodwin. The firm is headquartered in Conshohocken, Pennsylvania.

LGT Impact Ventures (UK) (LGT Impact Ventures) is a private equity subsidiary of LGT Group Foundation founded in 2014. The firm is headquartered in London, United Kingdom.

Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million.

Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.

Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.